ClinicalTrials.gg
RecruitingNCT07487181Updated Aug 26, 2026

A Survey of Traditional Medicine Pattern Identification in Patients With Erectile Dysfunction

An observational study in Erectile Dysfunctions, sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. Recruiting at 1 site in Vietnam. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by University of Medicine and Pharmacy at Ho Chi Minh City · Observational

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
375
Ages
18 Years and older
Sex
Male
01

Study summary

Erectile dysfunction (ED) is a common condition that significantly affects quality of life, psychological well-being, and interpersonal relationships. In Traditional Medicine, ED is classified into different syndrome patterns, which are essential for guiding individualized treatment; however, evidence on their distribution and associated factors in Vietnam remains limited. This cross-sectional study aims to determine the distribution of Traditional Medicine syndrome patterns in patients with ED and to evaluate their associations with demographic characteristics, clinical features, psychological status, and lifestyle factors, thereby providing evidence to support improved diagnosis and integrative treatment approaches.

Read the detailed description

This is a cross-sectional observational study designed to characterize the distribution of Traditional Medicine (TM) syndrome patterns among adult male patients with erectile dysfunction (ED) and to explore their associations with demographic, clinical, psychological, anthropometric, and lifestyle characteristics.

The study will be conducted at Binh Dan Hospital. Male patients aged 18 years or older who meet the study criteria for ED will be recruited during the study period. Erectile function will be assessed using the International Index of Erectile Function-5 (IIEF-5), a validated instrument used to identify and classify the severity of ED. Clinical information will be collected using a standardized data collection form.

TM syndrome patterns will be assessed according to predefined Traditional Medicine diagnostic criteria by appropriately trained clinicians. The assessment will be used to classify participants into the corresponding TM syndrome patterns. Demographic and clinical data will include age, educational level, age at first diagnosis of ED, ED severity, and relevant characteristics of erectile function. Anthropometric assessment will include body mass index (BMI), calculated from measured body weight and height. Information on relevant comorbidities, including hypertension, diabetes mellitus, and dyslipidemia, will also be recorded.

Psychological status will be assessed using the Depression Anxiety Stress Scales-21 (DASS-21), with the relevant subscale(s) used to characterize psychological symptoms. Lifestyle information will include smoking and alcohol consumption. All study variables will be collected at the time of enrollment, consistent with the cross-sectional design.

The analysis will first describe the distribution of TM syndrome patterns among participants with ED. Subsequently, the associations between TM syndrome patterns and selected demographic, clinical, psychological, anthropometric, comorbidity, and lifestyle characteristics will be examined. These analyses will include age, age at first diagnosis of ED, BMI, educational level, ED severity and clinical characteristics, psychological status, smoking, alcohol consumption, and selected comorbidities. The study is observational and cross-sectional; therefore, the analyses are intended to identify distributions and statistical associations rather than establish temporal or causal relationships.

02

Conditions studied

  • Erectile Dysfunctions

Browse trials for

Keywords

  • Traditional Medicine Pattern
  • Erectile Dysfunctions
  • IIEF-5
03

In context

Erectile Dysfunction

701 studies on the registry are indexed under Erectile Dysfunction; 125 are open to participants now.

This study's planned enrollment of 375 is above the median of 130 across 125 observational studies indexed under Erectile Dysfunction.

Browse Erectile Dysfunction studies →

Lead sponsor

University of Medicine and Pharmacy at Ho Chi Minh City is the lead sponsor of 127 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Individuals aged 18 years or older diagnosed with erectile dysfunction at Binh Dan Hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals aged 18 years or older who were diagnosed with erectile dysfunction by a clinical physician at Binh Dan Hospital between January 2026 and August 2026.
  • Willing to participate in the study and provide .

Exclusion criteria

Exclusion Criteria:

  • Unable to understand the questionnaire.
  • Unable to complete all the study questions.
  • Patients who do not wish to continue participating in the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
375 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Men aged ≥18 years diagnosed with erectile dysfunction at Binh Dan Hospital
06

What researchers measure

Primary outcomes

  1. Traditional medicine pattern identification

    Time frame: At the time of enrollment in the study

  2. Severity of erectile dysfunction according to the International Index of Erectile Function-5 (IIEF-5) score

    Erectile dysfunction severity will be assessed using the International Index of Erectile Function-5 (IIEF-5), a 5-item validated questionnaire assessing erectile function. The total score ranges from 5 to 25 points. Higher scores indicate better erectile function and less severe erectile dysfunction.

    Time frame: At the time of enrollment in the study

  3. Age, age at first diagnosis, BMI, educational level, severity of erectile dysfunction, clinical characteristics of penile erection in patients with erectile dysfunction, levels of depression, anxiety, and stress, comorbidities, and lifestyle factors

    Age: Years Age at first diagnosis of ED: Years Body Mass Index (BMI): kg/m², calculated as weight (kg)/height (m)² Educational level: Categorical Severity of ED: IIEF-5 score, 5-25; higher scores indicate better erectile function Clinical characteristics of penile erection: Categorical Depression: DASS-21 depression subscale, 0-42; higher scores indicate greater severity Anxiety: DASS-21 anxiety subscale, 0-42; higher scores indicate greater severity Stress: DASS-21 stress subscale, 0-42; higher scores indicate greater severity Comorbidities: Categorical (hypertension, diabetes, dyslipidemia) Smoking: Categorical Alcohol consumption: Categorical

    Time frame: At the time of enrollment in the study

  4. The associations between traditional medicine syndrome patterns and demographic, clinical, and lifestyle characteristics

    The associations between traditional medicine syndrome patterns and demographic, clinical, and lifestyle characteristics, including age, age at first diagnosis, body mass index (BMI), educational level, severity and clinical characteristics of erectile dysfunction, psychological status (stress), and lifestyle factors (smoking and alcohol consumption).

    Time frame: At the time of enrollment in the study

07

Study locations

1 of 1 sites recruiting
  • Binh Dan Hospital, Ho Chi Minh city
    Ho Chi Minh City, Vietnam
    Recruiting
08

References and documents

Publications

  • Van Vo T, Hoang HD, Thanh Nguyen NP. Prevalence and Associated Factors of Erectile Dysfunction among Married Men in Vietnam. Front Public Health. 2017 May 4;5:94. doi: 10.3389/fpubh.2017.00094. eCollection 2017. PubMed 28523265 ↗
  • Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW. Erectile Dysfunction: AUA Guideline. J Urol. 2018 Sep;200(3):633-641. doi: 10.1016/j.juro.2018.05.004. Epub 2018 May 7. PubMed 29746858 ↗
  • Capogrosso P, Albersen M, Burnett AL, Cakir OO, Deho F, Morgado LA, Mulhall J, Salonia A, Sarikaya AF, Satchi M, Serefoglu EC, Shabbir M, Sokolakis I, Yap T, Castiglione F. Erectile Dysfunction: Update on Clinical Management. Eur Urol. 2025 Oct;88(4):388-399. doi: 10.1016/j.eururo.2025.05.004. Epub 2025 May 19. PubMed 40393866 ↗

Related links

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2026 (actual). Primary completion is estimated for Sep 2026, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 17, 2026
First posted
Mar 23, 2026
StartActual
Jan 14, 2026
Primary completionEst.
Sep 30, 2026
CompletionEst.
Sep 30, 2026
Last update
Aug 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07487181
Responsible party
Bui Pham Minh Man (Doctor of Philosophy, University of Medicine and Pharmacy at Ho Chi Minh City) — Principal investigator
First posted
Mar 23, 2026
Start date
Jan 14, 2026
Primary completion
Sep 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Aug 26, 2026

Study contacts

Minh Man Bui Pham Doctor of Phylosophy
Contact
bpmman@uhsvnu.edu.vn
+84916080803
Giang Binh Pham Le Medical doctor
Contact
plgbinh.ths.yhct24@ump.edu.vn
+84346194876

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion